Great-West Lifeco (GWO) to Release Quarterly Earnings on Wednesday

Great-West Lifeco (TSE:GWO) will be issuing its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of C$1.02 per share for the quarter.

Great-West Lifeco (TSE:GWO) last released its earnings results on Wednesday, February 14th. The company reported C$1.04 earnings per share for the quarter, topping analysts’ consensus estimates of C$0.99 by C$0.05. Great-West Lifeco had a return on equity of 10.28% and a net margin of 7.95%. The business had revenue of C$20.21 billion for the quarter.

Great-West Lifeco Trading Down 0.0 %

GWO stock traded down C$0.01 during midday trading on Tuesday, reaching C$40.66. The company’s stock had a trading volume of 128,075 shares, compared to its average volume of 2,257,473. Great-West Lifeco has a 1 year low of C$37.06 and a 1 year high of C$45.18. The company has a debt-to-equity ratio of 32.33, a quick ratio of 22.18 and a current ratio of 12.42. The stock has a fifty day simple moving average of C$42.05 and a two-hundred day simple moving average of C$42.20. The firm has a market capitalization of C$37.91 billion, a price-to-earnings ratio of 13.88, a PEG ratio of 2.26 and a beta of 0.86.

Great-West Lifeco Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, March 28th. Stockholders of record on Thursday, February 29th were given a dividend of $0.555 per share. This is an increase from Great-West Lifeco’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend was Wednesday, February 28th. This represents a $2.22 dividend on an annualized basis and a dividend yield of 5.46%. Great-West Lifeco’s dividend payout ratio is presently 75.77%.

Analyst Ratings Changes

GWO has been the topic of several analyst reports. CIBC lifted their target price on Great-West Lifeco from C$44.00 to C$46.00 and gave the company a “neutral” rating in a research note on Friday, February 16th. TD Securities upped their price target on shares of Great-West Lifeco from C$44.00 to C$45.00 and gave the company a “hold” rating in a research note on Friday, April 12th. National Bankshares upped their price target on shares of Great-West Lifeco from C$40.00 to C$42.00 and gave the company a “sector perform” rating in a research note on Tuesday, January 23rd. BMO Capital Markets increased their price objective on shares of Great-West Lifeco from C$42.00 to C$44.00 and gave the stock a “market perform” rating in a research note on Thursday, January 25th. Finally, Scotiabank increased their price objective on shares of Great-West Lifeco from C$42.00 to C$44.00 and gave the stock a “sector perform” rating in a research note on Tuesday, February 6th. Seven investment analysts have rated the stock with a hold rating, According to MarketBeat, Great-West Lifeco currently has a consensus rating of “Hold” and an average price target of C$43.11.

Insider Transactions at Great-West Lifeco

In related news, Senior Officer Bradley John Fedorchuk sold 2,900 shares of the firm’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of C$42.44, for a total transaction of C$123,062.08. In other news, Senior Officer Linda Kerrigan sold 5,000 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of C$42.95, for a total value of C$214,750.00. Also, Senior Officer Bradley John Fedorchuk sold 2,900 shares of the firm’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of C$42.44, for a total transaction of C$123,062.08. Over the last three months, insiders have sold 13,300 shares of company stock valued at $566,402. Corporate insiders own 70.57% of the company’s stock.

About Great-West Lifeco

Great-West Lifeco Inc engages in the life and health insurance, retirement and investment services, asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers life, accidental death and dismemberment, disability, critical illness, health and dental protection, and creditor insurance products; and retirement and wealth savings, income and annuity products, and other specialty products to individuals, families, businesses, and organizations.